IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry

BACKGROUND: The relative contribution of isocitrate dehydrogenase mutations (mIDH) and O6-methylguanine-DNA methyltransferase promoter methylation (methMGMT) as biomarkers in glioblastoma remain poorly understood. METHODS: We investigated the association between methMGMT and mIDH with progression fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pei, Zhang, Wei, Wang, Yinyan, Peng, Xiaoxia, Chen, Baoshi, Qiu, Xiaoguang, Li, Guilin, Li, Shouwei, Wu, Chenxing, Yao, Kun, Li, Wenbin, Yan, Wei, Li, Jie, You, Yongping, Chen, Clark C., Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747376/
https://www.ncbi.nlm.nih.gov/pubmed/26503470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747376/
https://www.ncbi.nlm.nih.gov/pubmed/26503470

Ejemplares similares